NASA in nasal spray deal to combat motion sickness

CAPE CANAVERAL, Florida Sat Oct 13, 2012 2:26am IST

Related Topics

CAPE CANAVERAL, Florida (Reuters) - NASA has signed an agreement with a California-based startup to develop and market a nasal spray for motion sickness, the U.S. space agency said on Friday.

NASA will work with privately owned Epiomed Therapeutics of Irvine, California, on the nasal spray, which has been shown to be a fast-acting treatment for motion sickness.

About half the astronauts who fly in space develop space motion sickness, with symptoms that anyone nauseated or light-headed from more terrestrial forms of travel will recognize.

NASA has been working on giving astronauts an edge: a fast-acting medicine called intranasal scopolamine, or INSCOP. The drug also can be administered as a tablet, via a transdermal patch or injected, but a nasal spray can work faster and more reliably, NASA said.

"NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness," NASA researcher Lakshmi Putcha, with the Johnson Space Center in Houston, said in a statement.

In addition to partnering with NASA, Epiomed is working with the U.S. Navy to test the nasal spray.

Epiomed will assume responsibility for sponsorship of future clinical trials and for Federal Drug Administration approvals, NASA said. There has been no word on whether a prescription would be required for the nasal spray.

(Editing by Tom Brown, Gary Hill)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS EXCLUSIVE

HEALTH SHOWCASE

Marital Connection

Marital Connection

Spouse personality may affect career success  Full Article 

Influenza Vaccines

Influenza Vaccines

Plant-based vaccines challenge big pharma for $3 billion flu market  Full Article 

Ebola Outbreak

Ebola Outbreak

Traveler from Liberia is first Ebola patient diagnosed in U.S.  Full Article 

Birth Control

Birth Control

Long-acting reversible contraceptives best for teens: pediatricians.  Full Article 

Childhood Obesity

Childhood Obesity

Antibiotics in infancy may be linked to childhood obesity: study.  Full Article 

MERS Update

MERS Update

Austria reports first MERS case in Saudi national: media.  Full Article 

Sinusitis Drug

Sinusitis Drug

Sanofi-Regeneron drug has positive trial results in chronic sinusitis.  Full Article